株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

チェディアック・東症候群:世界の治験動向

Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2018

発行 GlobalData 商品コード 318329
出版日 ページ情報 英文 41 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.72円で換算しております。
Back to Top
チェディアック・東症候群:世界の治験動向 Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2018
出版日: 2018年12月31日 ページ情報: 英文 41 Pages
概要

当レポートでは、チェディアック・東症候群に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、G7およびE7諸国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んでお届けします。

当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 主要国における治験件数; 欧州
    • 主要国における治験件数; 北米

G7諸国における治験件数:チェディアック・東症候群治験数の遺伝性疾患治験数に対する比率

フェーズ(相)別治験件数: G7諸国

G7諸国における治験件数:フェーズ(相)別

フェーズ(相)別治験件数

  • フェーズ(相)別の進行中治験件数

進捗状況別の治験件数

評価項目別の治験件数

一定期間に採用された被験者数

スポンサーの種類別治験件数

有望なスポンサー

治験主要参加企業 - チェディアック・東症候群 治療薬

有望な薬剤

治験プロファイルの基本情報

付録

図表

図表

List of Tables

  • Chediak-Higashi Syndrome Therapeutics, Global, Clinical Trials by Region, 2018* 7
  • Chediak-Higashi Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Chediak-Higashi Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
  • Chediak-Higashi Syndrome Therapeutics Clinical Trials, Europe, Top Countries, 2018* 10
  • Chediak-Higashi Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2018* 11
  • Proportion of Chediak-Higashi Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2018* 13
  • Chediak-Higashi Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 14
  • Chediak-Higashi Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 15
  • Chediak-Higashi Syndrome Therapeutics, Global, Clinical Trials by Phase, 2018* 16
  • Chediak-Higashi Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 17
  • Chediak-Higashi Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2018* 18
  • Chediak-Higashi Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2018* 19
  • Chediak-Higashi Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 20
  • Chediak-Higashi Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 21
  • Chediak-Higashi Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 22
  • Chediak-Higashi Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 23
  • Chediak-Higashi Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 24

List of Figures

  • Chediak-Higashi Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
  • Chediak-Higashi Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Chediak-Higashi Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
  • Chediak-Higashi Syndrome Therapeutics Clinical Trials, Europe, Top Countries (%), 2018* 10
  • Chediak-Higashi Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 11
  • Proportion of Chediak-Higashi Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2018* 12
  • Chediak-Higashi Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 14
  • Chediak-Higashi Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 15
  • Chediak-Higashi Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2018* 16
  • Chediak-Higashi Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 17
  • Chediak-Higashi Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2018* 18
  • Chediak-Higashi Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2018* 19
  • Chediak-Higashi Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 20
  • Chediak-Higashi Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 21
  • Chediak-Higashi Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 22
  • Chediak-Higashi Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 23
  • Chediak-Higashi Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 24
  • GlobalData Methodology 40
目次
Product Code: GDHC5541CTIDB

GlobalData's clinical trial report, "Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2018" provides an overview of Chediak-Higashi Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Chediak-Higashi Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

  • Table of Contents 2
    • List of Tables 3
    • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
    • Clinical Trials and Average Enrollment by Country 8
      • Top Countries Contributing to Clinical Trials in Europe 10
      • Top Countries Contributing to Clinical Trials in North America 11
  • Clinical Trials by G7 Countries: Proportion of Chediak-Higashi Syndrome to Genetic Disorders Clinical Trials 12
  • Clinical Trials by Phase in G7 Countries 14
  • Clinical Trials in G7 Countries by Trial Status 15
  • Clinical Trials by Phase 16
    • In Progress Trials by Phase 17
  • Clinical Trials by Trial Status 18
  • Clinical Trials by End Point Status 19
  • Subjects Recruited Over a Period of Time 20
  • Clinical Trials by Sponsor Type 21
  • Prominent Sponsors 22
    • Top Companies Participating in Chediak-Higashi Syndrome Therapeutics Clinical Trials 23
  • Prominent Drugs 24
  • Clinical Trial Profile Snapshots 25
  • Appendix 39
    • Abbreviations 39
    • Definitions 39
    • Research Methodology 40
    • Secondary Research 40
    • About GlobalData 40
    • Contact Us 41
  • Source 41
Back to Top